Back to mobile site

Edwards Lifesciences Corp. (EW) Tops Q1 EPS by 9c; Increases FY11 EPS Outlook, Guides Q2

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/21/2026

1. SPCX
2. NVDA
3. NFLX
4. ISRG
5. TSLA
6. META
7. RTX
8. SMCI
9. GOOGL
10. S

April 20, 2011 4:05 PM EDT
Edwards Lifesciences Corp. (NYSE: EW) reported Q1 EPS of $0.51, $0.09 better than the analyst estimate of $0.42. Revenue for the quarter came in at $404.5 million versus the consensus estimate of $384.15 million.

Sees Q2 2011 EPS of $0.49-$0.51, versus the consensus of $0.47.

Increases FY2011 EPS form $1.91 - $1.97 to $2.01-$2.07, versus the consensus of $1.95. Sees FY2011 revenue of $1.66-$1.74 billion, versus the consensus of $1.63 billion.

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance, Hot Guidance